Used in peptide synthesis as a chiral building block for the preparation of structurally constrained peptides. The Fmoc group allows for solid-phase synthesis by providing orthogonal protection for the amine function, while the (2S,5R)-5-phenylpyrrolidine-2-carboxylic acid moiety introduces a rigid, stereochemically defined turn-inducing element into the peptide backbone. This makes it valuable in the design of peptidomimetics and bioactive compounds where conformational control enhances receptor selectivity, metabolic stability, or binding affinity. Commonly applied in medicinal chemistry for developing enzyme inhibitors and receptor modulators.